Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · IEX Real-Time Price · USD
4.120
-0.080 (-1.90%)
At close: Jul 2, 2024, 4:00 PM
4.200
+0.080 (1.94%)
After-hours: Jul 2, 2024, 6:00 PM EDT
Abeona Therapeutics Market Cap
Abeona Therapeutics has a market cap or net worth of $168.77 million as of July 2, 2024. Its market cap has increased by 80.89% in one year.
Market Cap
168.77M
Enterprise Value
129.25M
1-Year Change
80.89%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since March 30, 2000, Abeona Therapeutics's market cap has increased from $78.00M to $168.77M, an increase of 116.37%. That is a compound annual growth rate of 3.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 173.00M | 39.40% |
Dec 29, 2023 | 124.10M | 134.59% |
Dec 30, 2022 | 52.90M | 54.23% |
Dec 31, 2021 | 34.30M | -77.83% |
Dec 31, 2020 | 154.70M | -7.53% |
Dec 31, 2019 | 167.30M | -51.12% |
Dec 31, 2018 | 342.30M | -53.83% |
Dec 29, 2017 | 741.40M | 282.56% |
Dec 30, 2016 | 193.80M | 76.18% |
Dec 31, 2015 | 110.00M | 5,689.47% |
Dec 31, 2014 | 1.90M | -70.31% |
Dec 31, 2013 | 6.40M | 10.34% |
Dec 31, 2012 | 5.80M | -82.63% |
Dec 30, 2011 | 33.40M | -15.87% |
Dec 31, 2010 | 39.70M | -7.89% |
Dec 31, 2009 | 43.10M | 563.08% |
Dec 31, 2008 | 6.50M | -43.97% |
Dec 31, 2007 | 11.60M | 17.17% |
Dec 29, 2006 | 9.90M | 7.61% |
Dec 30, 2005 | 9.20M | -83.24% |
Dec 31, 2004 | 54.90M | -21.57% |
Dec 31, 2003 | 70.00M | 255.33% |
Dec 31, 2002 | 19.70M | -65.50% |
Dec 31, 2001 | 57.10M | -10.64% |
Dec 29, 2000 | 63.90M | -18.08% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
908 Devices | 177.60M |
Butterfly Network | 177.16M |
Alpha Tau Medical | 176.59M |
Biodesix | 175.47M |
INmune Bio | 174.48M |
Outlook Therapeutics | 172.73M |
Fennec Pharmaceuticals | 166.94M |
FibroBiologics | 163.27M |